Letter to President Donald Trump

Treated v Sham

Game Changing Treatment for COVID-19

MAHWAH, NEW JERSEY, UNITED STATES, April 2, 2020 /EINPresswire.com/ — April 1, 2020

President Donald Trump
The White House
1600 Pennsylvania, Avenue
Washington, D.C.20500

Dear Mr. President

The most promising treatment for COVID-19 can be found in the files of FDA’s Center for Devices and Radiological Health (CDRH) and the National Institute of Health. I know that because in 2006 during the fear of an H5N1 (bird flu) pandemic the FDA asked if my company would work with them to determine if a therapy we were perfecting would be a safe and effective treatment for H5N1.I invite you to view the simple 20-minute process of UBI on our website globalpandemicconsortium.com.

FDA’s interest in our technology was based in part on the results of our research that they reviewed and approved as follows:
1. An in-the lab study of SARS resulted in near complete inactivation of the virus after just 10-seconds of exposure

2. A study of rhesus monkeys infected with SIV conducted at one of the seven national primate centers (TNPC) established dramatic reductions in viral loads, causing the researchers to opine that the results were “unprecedented”.

3. A phase I study reviewed and approved by the FDA of human patients infected with the hepatitis C virus established significant reductions in viral load of 50-80%, and a second study established similar reductions while some patients experienced an improvement in liver function.

4. Based in part on the results above and additional safety studies in June of 2008, FDA granted us approval to conduct the first study ever of a non-drug treatment for humans infected with HIV.
Due to the high cost of H5N1 research at the time, we worked with FDA and designed a two-phase program. The first phase of the research was conducted in 60 mice infected with H1N1 and separated into 2 groups. One group (30 mice) were treated with the therapy while the remaining mice received a sham treatment. The results of that research are summarized as follows:

Overall, treatment of influenza-infected animals produced discernible and substantial improvement in both clinical disease and pulmonary function.

• A critical parameter in respiratory infections is a patient’s ability to breathe. As measured by pulmonary function testing, infected animals that were treated exhibited a significantly greater ability to breathe relative to their sham-treated counterparts.

• The inability to breathe in influenza-infected individuals is generally associated with cellular inflammation in the airways of the lung that obstructs these passageways. Pathological examination of lungs clearly indicated that the treatment significantly inhibited virus-induced inflammation, resulting in airways that were, for the most part, clear of inflammatory cells and cellular debris (green arrows). In contrast, the lungs of the sham-treated mice had airways that were filled with inflammatory cells and blood and exhibited substantial destruction of the cells lining them (red arrows).

• The experimental treatment appears to modulate specific arms of the immune response, thereby limiting the scope and severity of clinical and pulmonary disease normally associated with the body’s response to influenza infection. This has important implications in that the therapy may be effective irrespective of the virus’s antigenic subtype or susceptibility to antiviral medications.

The last finding is the most interesting, as it suggests that the treatment could be effective against any pandemic virus regardless of its name or strain.

A meeting with representatives of the National Institutes of Health (NIH) was held to discuss funding for the additional research and determine their interest in preparing the devices that would be needed to rapidly respond to a pandemic. Although NIH agreed with FDA that the results were very promising, the bird flu threat had waned, as did their interest in preparing for it or any yet identified pandemic and the research was suspended.

Although now retired, the potential of a significant loss of life due to the COVID-19 pandemic has caused me to resurrect the considerable research we were conducting. In that regard, I have been in communication with officials at CDRH to discuss a study that has been designed by researchers at one of the seven national primate centers.

As you are aware the regulations for reviewing and clearing medical devices are less rigorous than those for drugs and other pharmacological therapies. Specifically, FDA regulation 510K allows for a 90-day clearance for a device that can be shown to be substantially equivalent to a device that was commercially available prior to December 1976. Although we believe our technology would be a candidate for such a clearance, in the event FDA disagrees, we are committed to working with them to obtain the clearance expeditiously.

The potential benefits of the technology / treatment are numerous……

Safety – it should prove to be safe as it has been administered hundreds of times without an adverse event.

Effectiveness – research has established its ability to inactivate RNA type viruses such as COVID-19 as well an ability to treat respiratory conditions such as pneumonia, a serious complication of COVID-19.

Rapid and ease of administration: The device is the size and weight of a brief case allowing for the treatment to be administered in the comfort of a patient’s home in a matter of 20 minutes.

Multipurpose: There is a high likelihood if proven to reduce viral load in COVID-19 patients it will reduce the virus of the next pandemic and the one after that.

Mr. President, we applaud you for your interest and efforts to pull out all stops to find the
‘game changer” to treat COVID-19. I believe this therapy is a critical piece of the solution everyone is searching for and hope there is a way for us to partner with the federal government to expedite the testing, manufacture and distribution of the therapy to the healthcare providers that can utilize it.

Thank you for all you are doing to end this terrifying pandemic and for your time and interest in this important matter.

I remain,

Thomas J. Fagan
Founder

E: tfagan@globalpandemicconsortium.com
C: 201-458-2683

THOMAS FAGAN
Global Pandemic Consortium
2014582683
email us here
Visit us on social media:
Facebook

Process of ultraviolet blood irradition


Source: EIN Presswire

NC Biotech Validates Sustainable Infectious Disease Testing Resource

“Horseshoe Crab Aquaculture as a Sustainable Endotoxin Testing Source” has been published online by Frontiers in Marine Science, an open-source journal.

“Horseshoe Crab Aquaculture as a Sustainable Endotoxin Testing Source” has been published online by Frontiers in Marine Science, an open-source journal.

Senior Kepley Scientist and lead author, Dr. Rachel Tinker-Kulberg, with recent publication.

Senior Kepley Scientist and lead author, Dr. Rachel Tinker-Kulberg, with recent publication.

Horseshoe crab hemolymph (“Blue Blood”) antimicrobial hemacyanin fraction (left); Limulus Amebocyte Lysate (LAL) fraction reacting with bacterially contaminated human blood (right).

Horseshoe crab hemolymph (“Blue Blood”) antimicrobial hemacyanin fraction (left); Limulus Amebocyte Lysate (LAL) fraction reacting with bacterially contaminated human blood (right).

GREENSBORO, NORTH CAROLINA, USA, April 2, 2020 /EINPresswire.com/ — Kepley BioSystems Inc, a North Carolina biotech has just published the results of their endotoxin testing research in the Marine Conservation and Sustainability section of Frontiers in Marine Science. With grant funding from the National Science Foundation, the team validated novel methods of Atlantic horseshoe crab aquaculture for sustainable production of a resource used to ensure the safety of human medicine, worldwide.

The article is entitled “Horseshoe Crab Aquaculture as a Sustainable Endotoxin Testing Source.” The work presents key findings with disruptive potential to supply materials for established pharmaceutical and biomedical device sterility testing while eliminating the annual capture of hundreds of thousands of animals from the wild. The research has also laid the groundwork for applying the unparalleled sensitivity of this resource to the detection of blood-borne bacterial infections in clinical medicine. Notably, many such cases share early symptoms and can occur in the course of treating Covid-19. Kepley BioSystems is continuing its efforts toward a rapid test to help distinguish between such causes.

“Modern medicine depends on a unique cell in horseshoe crab blood to test and ensure the safety of vaccines, medical devices, and implants for millions of patients every year,” stated senior scientist and lead author, Rachel Tinker-Kulberg. “We owe a huge debt to these creatures and their amazing immune system. Our new methods can not only safeguard the well-being of the horseshoe crabs in aquaculture, but industry scale-up and adoption would spare upwards of 90% of those captured to meet current demand in year one – and annually leave some 600,000 of them in the wild for many years thereafter.”

“Encouraged by meeting crucial milestones, we’re seeking further grants and eventually a commercial partner to develop a rapid gram-negative blood test to detect pathogens that can lead to sepsis, while carefully targeting antibiotics in an era of antimicrobial resistance,” said Anthony Dellinger, president of Kepley BioSystems. “With overlapping patient symptoms, detecting bacterial infections could help ensure timely treatment, especially given Covid-19 testing challenges in this pandemic wreaking havoc on society and investors.”

Sepsis was well established as the leading cause of untimely death before the current pandemic. These dynamics can exponentially increase the potential impact of sepsis wherever co-infections follow Covid-19 trends going forward. Given nearly 50 million cases and 11 million sepsis-related deaths per year before the novel coronavirus outbreak, early detection of the onset of sepsis is more important than ever; wherein, appropriate administration of antimicrobial treatment can reduce mortality rates by 7.6% per hour.

“Horseshoe Crab Aquaculture as a Sustainable Endotoxin Testing Source ” is an open-access publication and can be read online at the Frontiers for Marine Science site, frontiersin.org.

###

About Kepley BioSystems:
Kepley BioSystems is a North Carolina-based life sciences biotech operating out of Gateway Research Park (GRP) in collaboration with the Joint School of Nanoscience and Nanoengineering (JSNN), comprised of a partnership between the North Carolina Agriculture and Technical State University (NCA&T) and the University of North Carolina at Greensboro (UNCG). Kepley BioSystems was founded in 2013 with a mission to emerge disruptive innovations to achieve global solutions. Having been primarily grant-funded to date, Kepley is seeking commercial partners and/or equity investors to help realize its full potential in multi-billion dollar markets across the company’s project portfolio. For more information, visit: http://www.kepleybiosystems.com/

About Frontiers in Marine Science:
Frontiers in Marine Science publishes rigorously peer-reviewed research that advances understanding of all aspects of the environment, biology, ecosystem functioning and human interactions with the oceans. Field Chief Editor Carlos M. Duarte at King Abdullah University of Science and Technology Thuwal is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, policy makers and the public worldwide.

Lee Robertson
Kepley BioSystems Inc
+1 336-217-5163
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Feed Families… Support Restaurants… Save Jobs

Major General Craig Whelden U.S Army (Retired)

Major General Craig B. Whelden, U.S. Army (Retired)

LOS ANGELES, CA, UNITED STATES, April 1, 2020 /EINPresswire.com/ — Like many of you, I’m at home watching the deadly Coronavirus crisis unfold. But, I’m more fortunate than most. My wife and I are healthy and we have the means to weather this economic storm. I have a steady retirement income and no mortgage. Both my kids are out of college and on their own. I have no job to go to, no debt, few obligations, no worries, and plenty of discretionary time. I can easily wait this out.

Millions are not so lucky.

I live in Bluffton, South Carolina, just outside Hilton Head, a destination resort providing world class leisure, entertainment, and eating options. All that has now ground to a halt. Especially hard hit is the hospitality industry. Because all restaurants have been closed to inside dining, this part of the workforce is facing an unprecedented and sudden financial crisis like none of us have ever seen or experienced. The recent Congressional actions will help, but will not be enough.

At the height of the Great Depression, President Roosevelt said “The test of our progress is not whether we add more to the abundance of those who have much; it is whether we provide enough for those who have too little.” These words have as much application now as they did then; as millions of Americans are losing their jobs. So how can “those of us who have much” help “those who have too little?”

Last weekend, I called the President of Hilton Head’s Chamber of Commerce asking how I can help. Bill Miles directed me to an incredible initiative by a local entrepreneur that will help shore up the objectives spelled out in the title of this article.

Watterson Family Foundation, partnering with local Chambers of Commerce, a team of local leaders, social service providers, food banks, churches, and with the support of local governments – has devised a turn-key program that delivers $50 “Community Investment Cards” to those most economically affected by this pandemic to be redeemed through curb-side pickup at one of dozens of local restaurants.

Through donations from people like me…and many others, this initiative feeds families, helps restaurants stay open, and keeps many restaurant workers employed. After speaking with Billy Watterson, I immediately signed on to help.

Learn more how this works at www.help4hopenow.org. This could easily be adapted to your community. And, if you have questions about how to set this up in your own back yard, feel free to contact me at wheldencraig@gmail.com.

Together, we can…

“…Feed Families… Support Restaurants… Save Jobs.”

—————————————-

Major General Craig Whelden, U.S. Army (Retired) served 30 years in an Army uniform followed by another nine as a member of the Senior Executive Service for the Marine Corps. He is a motivational speaker on leadership and life lessons and is the author of the multiple award-winning, #1 international best-selling book, LEADERSHIP: The Art of Inspiring People to Be Their Best. Learn more at www.craigwhelden.com.

Aurora DeRose
Michael Levine Media
+1 951-870-0099
email us here


Source: EIN Presswire

Bored Beverly Hills Surgeon Opens His Calendar & Is Giving Away Over $6,000 Worth of Virtual Consultations to 30 People

Dr. Robert Kotler

"These are economically uncertain times for all, so while we usually charge $200 for our Virtual Consultations, we have decided to waive our fee for 30 people."

LOS ANGELES, CA, UNITED STATES, April 1, 2020 /EINPresswire.com/ — Timing is everything, Dr. Robert Kotler, MD, FACS, Beverly Hills super-specialist in nasal cosmetic and reconstructive surgery, has never had so much downtime, and he hates it.

“In my 30+ years in practice, I’ve never had as much downtime as I do today. Covid-19 has the US and much of the world on lockdown, and as a result I’m not able to complete the favorite part of my job, seeing patients in my office.”

Thankfully Dr. Kotler’s office has been ahead of the technology curve and has long-offered prospective patients, worldwide, remote consultations. Via SKYPE or FaceTime, Dr. Kotler visually examines the nose, discusses the patient’s desires and can render an opinion as to whether surgical or permanent non-surgical (liquid) rhinoplasty would be the best solution. Or, perhaps, he’ll say, “You look good, save your time and money.” These remote consultations are very popular, and his office typically charges $200.

Dr. Kotler notes, “Being a doctor is the biggest part of my life. There is nothing I enjoy more than seeing and helping patients in my office. But because we are now prohibited by law from operating and cannot see patients in the office, my schedule has opened up, allowing more time for Virtual Consultations. And the fact is, these are economically uncertain times for all, so while we usually charge $200 for our Virtual Consultations, we have decided to waive our fee for 30 people. We’re all in this together…”

If you’ve been considering rhinoplasty or permanent non-surgical (liquid) rhinoplasty, now would be a good time to take the next step and schedule your Virtual Consultation.

To schedule your Virtual Consultation, contact Yvonne or Mary at Dr. Kotler’s office today at: 310-278-8721, M-F,9-5, Pacific Time

E-mail: info@RobertKotlerMD.com

Schedule online at: https://www.robertkotlermd.com/nose/learn-more-contact-us/

Jaaron Jennings
Michael Levine Media
+1 9518700099
email us here


Source: EIN Presswire

Boy With Autism Has Video Go Viral After Featuring His Heartwarming Invention

malachi mitchell and his roller necklace invention

Malachi Showing Off His Invention

10 Year Old Malachi Mitchell created an ingenious tool to help kids & adults with anxiety, and his viral video demonstrates this touching story.

I've always wanted to be an inventor and build all kinds of cool gadgets and robots and stuff, but sometimes it's hard to do things with autism”

— Malachi Mitchell

SAN CLEMENTE, CA, USA, April 1, 2020 /EINPresswire.com/ — For Immediate Release

Just in Time for Autism Awareness Month in April, A young autistic boy has come up with an ingenious idea to harness the power of a trending beauty tool and take it to new heights!

Gemstone facial rollers have become a must-have beauty item on many women’s shelves over the last couple of seasons. The handheld tool has rollable gemstones like jade or rose quartz on either end and beauty buffs say they offer an instant cooling and relaxing facial treatment that helps to drain excess fluid and toxins from the skin and increase circulation.

Ten-year-old Malachi Mitchell was fascinated by the tool while watching his mother use it in the evenings. It wasn’t long before he was trying it out on himself, rolling it on his arms and neck, which he found soothing. As a child with autism and ADHD, anxiety is a common occurrence and Malachi’s mother Alana was relieved to find something that calmed his nerves.

“I wanted my mom to bring the roller with us everywhere so I could use it whenever I wanted, but we couldn't really do that because it was too big,” explains Malachi.

It was then that the aspiring inventor came up with the brilliant idea to turn the roller into a necklace that he could take on the go.

“Our jaws dropped when we heard his idea, then dropped again when we realized that his idea was completely unheard of,” said Alana, “Malachi has struggled in the past with bullies and other children not understanding how he is, but the process of inventing a successful product and obtaining a patent has really given him a boost of confidence!”

The gemstone necklaces can be used for people and children like Malachi who enjoy tactile stimuli, or as a stress reliever for those who feel the need to fidget, or even as a tool to cultivate mindfulness or awareness.

“I've always wanted to be an inventor and build all kinds of cool gadgets and robots and stuff, but sometimes it's hard to do things with autism,” says Malachi, “My mom says we need people like me in the world because we think differently!”

ENDS

Alana Mitchell
alanamitchell.com
+1 949-292-0544
email us here
Visit us on social media:
Facebook

Malachi Mitchell explains his new invention!


Source: EIN Presswire

100 Year Old Frequency Therapy Could Hold the Future of Medicine in Both Chronic and Acute Conditions

tucson biofeedback, tucson biofeedback staff, Dr. Anna Blessing, Tucson Wellness Services

Tucson Biofeedback’s Staff

tucson biofeedback, tucson biofeedback staff, Dr. Anna Blessing, Tucson Wellness Services

Tucson Biofeedback Services

Breakthrough Frequency Therapies that Boost Health and Immunity in Today’s Age Could Shift the Way we View Health

A single four minute exposure to a frequency combination caused a permanent change in immune system function as measured two weeks after the treatment. ”

— Dr. Vivienne Reeve

TUCSON, ARIZONA, UNITED STATES, April 1, 2020 /EINPresswire.com/ — Breakthrough Frequency Therapies that Boost Health and Immunity in Today’s Age could Shift the way we view health.

Tucson is the home to a Wellness Clinic, Tucson Biofeedback that is devoted completely to utilizing Biofeedback, Neurofeedback, Microcurrent, and other Frequency Therapies. Frequency Therapies have been around for over 100 years, but it wasn’t until recently that advancement sin technology gave us the ability to track and see how it improves function in our body and brain.

Many people suffer today from low or limited energy levels which is directly related to Mitochondria function.

According to the Cleveland Clinic: “Mitochondrial dysfunction occurs when the mitochondria do not work as well as they should due to another disease or condition. Many conditions can lead to secondary mitochondrial dysfunction and affect other diseases, including Alzheimer's disease, muscular dystrophy, Lou Gehrig's disease, diabetes and cancer.”

Mitochondria are responsible for our ATP or cellular energy, when there is a lack of mitochondria our energy, brain and body suffers breaking down over time. Frequency Specific Microcurrent available in Tucson at Tucson Biofeedback are able to apply specific applications of these frequencies, which is said to boost Mitochondria production by up to 500%.

According to the Cleveland Clinic and published papers on FSM, “Frequency Specific Microcurrent increases ATP Production by 500%, increases protein synthesis by 70%, increases amino acid transport by 40% and increases cAMP in human lymphocytes – in vivo. It also activates signal transduction.” All of this equates to highly effective support in reducing challenges from conditions like: fibromyalgia, headaches, chronic muscle pain, injuries, immunity even asthma and kidney stones.”

Additionally, Frequency Specific Microcurrent have produced some impressive and unparalleled results in Immune Function.

According to multiple studies carried out at The University of Sydney in Australia by Dr. Vivienne Reeve: “The frequency thought to “reduce inflammation in the immune system” was studied in an animal research laboratory at University of Sydney in Australia by Dr. Vivienne Reeve. Arachadonic acid was painted on the ears of hairless mice. Arachadonic acid causes inflammation mediated by lipoxygenase prostaglandin pathways and causes swelling. This animal model is an accepted way to study inflammation and has been used to study virtually every anti-inflammatory drug or therapy. The frequency combination reduced swelling by 62% in four minutes in every animal tested with everyone in the lab blinded and as tested against a placebo frequency. Prescription and non-prescription drugs tested in this animal model reduced swelling by 45%. Placebo frequency had no effect on swelling. None of the three other frequency combinations tested in this animal model reduced inflammation at all. The frequency response was time-dependent. 50% of the effect was present at 2 minutes, 100% of the effect was present at 4 minutes and further time spent on the frequency had no additional effect. This is the only frequency combination that has been studied in an animal model but the effects and the implications are important. A single four minute exposure to a frequency combination caused a permanent change in immune system function as measured two weeks after the treatment. “

Tucson Biofeedback is currently accepting new patients and they remain open as an essential business through the COVID19 epidemic.

Dr. Anna Blessing
Tucson Biofeedback
+1 5203146894
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Melissa Bamberg, NodPod Founder, Giving 25% Off NodPod Orders To Help People Sleep During Stressful Coronavirs Pandemic

nodpod

“At nodpod, good sleep is what we stand for. If you sleep better, you live better.”

LOS ANGELES, CA, UNITED STATES, April 1, 2020 /EINPresswire.com/ — Stress and a lack of sleep affect the immune system and make us more vulnerable to opportunistic infection, such as COVID-19. One of the leading practices that can help decrease stress, according to the CDC, is to get better sleep.

Melissa Bamberg, Founder of nodpod, has much to say on the crucial need of sleep during these difficult times. “At nodpod, good sleep is our mission. If you sleep better, you live better."

“The Weighted Blanket for Your Eyes”, is a patented weighted sleep mask that is like a hug for your head. This weighted eye mask features four microbead-filled pods that not only block out the light, but also apply gentle pressure on your eyes to help you fall asleep faster and better. Featuring a cool jersey cotton surface with a warm microfleece reverse, this sleep therapy mask feels good in all seasons, while the open-ended design ensures that you'll stay comfortable in different sleeping positions.

With nodpod, you can sleep in any position. Just lay it over your eyes, and sink into your best night’s sleep. There’s no uncomfortable strap or velcro. The scent-free microbeads create a custom fit that perfectly blocks light while the gentle weight naturally takes away stress and anxiety. Nodpod isn’t just about blocking light, it’s about helping your body naturally relax and ease into a deep, restorative sleep.

"Reducing the physical manifestations of stress and anxiety in our body helps us to remain physically healthy during stressful times” says Blake McKinney, MD, an emergency physician in California, "That’s why sleep matters. When we get meaningful sleep, our immune systems are better able to protect us from infection."

For the next 30 days, nodpod is offering 25% off your entire order with the sleep code: SLEEPMATTERS.

Nodpod inventory is maintained in a COVID-free environment in it’s California warehouse. All operational staff work remotely while one well staff member fulfills each order directly on a daily basis.

Aurora DeRose
Michael Levine Media
+19518700099
email us here


Source: EIN Presswire

Switchgear Market to Cross $ 155 Billion by 2025 | TechSci Research

Strict environmental regulations along with increasing focus towards conservation of energy to drive global switchgear market through 2025

NEW YORK, NEW YORK, UNITED STATES, April 1, 2020 /EINPresswire.com/ — Strict environmental regulations along with increasing focus towards conservation of energy to drive global switchgear market through 2025

According to TechSci Research report, “Global Switchgear Market By Insulation, By Installation, By Voltage, By Product, By End User, By Region, Competition, Forecast & Opportunities, 2025”, the global switchgear market is projected to surpass $ 155 billion by 2025 on account of increasing demand for electricity, growing implementation of smart grid technology, and rising investment in upgrading transmission and distribution systems. The global switchgear market is segmented based on insulation, installation, voltage, product, end user, region and company. Based on insulation, the market can be categorized into air insulated, gas insulated and others. The gas insulated segment is likely to dominate the market owing to their feature of serving different needs at varying voltage levels in various end user industries.

Browse 167 market data Figures spread through 120 Pages and an in-depth TOC on "Global Switchgear Market"

https://www.techsciresearch.com/report/switchgear-market/4127.html

Based on installation, the market can be divided into indoor and outdoor, of which the latter is projected to register the highest CAGR during the forecast period on account of their use in transmission and sub-transmission sectors. Based on voltage, the market can be fragmented into low, medium and high. The low voltage segment is expected to hold the largest market share and dominate the market during forecast period on account of high demand. Based on end user, the market can be segmented into Transmission & Distribution Utilities, Industrial, Commercial, Residential and Others. The Transmission & Distribution Utilities segment is expected to continue its dominance during the forecast period.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4127

Customers can also request for 10% free customization on this report.

Bharat Heavy Electricals Ltd., Mitsubishi Electric Corporation, CG Power and Industrial Solutions Limited, Siemens Aktiengesellschaft, General Electric Company, Eaton Corporation plc, ABB Ltd., Alstom SA, Schneider Electric SE, and Havells India Limited are some of the leading players operating in the global switchgear market. “Asia-Pacific switchgear market is expected to be the largest market during the forecast period. Countries such as China and India are undertaking a large number of smart grid and substation projects to fulfil the growing demand for energy. This factor would drive the switchgear market in the region over the course of next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Switchgear Market By Insulation, By Installation, By Voltage, By Product, By End User, By Region, Competition, Forecast & Opportunities, 2025” has evaluated the future growth potential of global switchgear market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global switchgear market.

About TechSci Research

TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.

Contact

Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

New Age TechSci
New Age TechSci Research Pvt Ltd
+ +1 646 360 1656
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Dr. Robert E. Windsor of Georgia RegenRX to be Featured on Close Up Radio

CUMMINGS, GEORGIA, UNITED STATES, April 1, 2020 /EINPresswire.com/ — Chronic pain is pain lasting over six months that's functionally interfering with your quality of life that cannot be controlled by over-the-counter medications.

For years the only way to address chronic pain has been through pain management. The term pain management implies that we’re not trying to improve situation, only make it bearable. Regenerative Medicine is the next level.

With over three decades in practice as a pain and regenerative medicine specialist, Dr. Robert Windsor, MD, has helped countless patients recover from pain, improve their functionality, and improve their quality of life.

Throughout his career, Dr. Windsor has studied, taught, and worked extensively in the fields of interventional pain medicine, interventional orthopedics, regenerative medicine (like stem cell therapy), integrative medicine and pain management for arthritis, chronic spinal pain, and sports medicine to name only few.

Dr. Windsor has seen some brilliant results with otherwise chronic cases without the need for surgery, opiates or cortisone.

According to Dr. Windsor, a patient’s inflammatory status influences the body's capacity to heal. It also influences the body’s manifestation of disease such as diabetes, hypertension, heart disease, hypercholesterolemia, and cancer. Regenerative medicine reduces not only reduces inflammation but speeds the healing process through directing growth factors and other natural chemicals directly to the site of injury.

“Regenerative medicine is about creating the ideal environment for healing. The body naturally heals. It wants to heal. it wants to reach balance. So it's about using the body's inherent healing powers and supercharging them.”

Highly published in the pain and sports medicine literature, Dr. Windsor has been board-certified in physical medicine, electrodiagnostic medicine, pain medicine, pain management, anti-aging medicine, regenerative medicine, and soon, aesthetic medicine.

Close Up Radio will feature Dr. Robert E. Windsor in an interview with Jim Masters on April 3rd at 2pm EDT

Listen to the show on BlogTalkRadio

If you have any questions for our guest, please call (347) 996-3389

For more information, visit www.garegenrx.com

Lou Ceparano
Close Up Television & Radio
+1 631-850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Kidney Medicine Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2020 – 2026

Latest Market Analysis Research Report on “Global Kidney Medicine Market” has been added to Wise Guy Reports database.

PUNE , MAHARASHTRA, INDIA, April 1, 2020 /EINPresswire.com/ — Global Kidney Medicine Industry

New Study On “2020-2026 Kidney Medicine Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

Overview

This research on the Global Kidney Medicine Market provides an objective analysis of the overall market based on the latest data. The description in the report offers a comprehensive overview of the industry along with the definition of the goods and services. The research also presents the forecast for the Global Kidney Medicine Market, with an analysis covering the period 2020-2026. The report provides an in-depth analysis of the key trends that decide the market's future in terms of overall growth and value in the coming years.

Try Sample of Global Kidney Medicine Market @  https://www.wiseguyreports.com/sample-request/5123242-global-kidney-medicine-market-research-report-2020

The major players in global Kidney Medicine market include:
Pfizer, Roche, Sanofi, Novartis, Amgen, Xiuzheng Pharmaceutical Group, Xiaolin Zhiyao, Henan Lingrui Pharmaceutical, Kuihua yaoye, Sanjiu Pharmaceutical, Harbin Pharmaceutical Group

Key Players

In terms of their strategic profiles and business details, all the key players in the Global Kidney Medicine Market have been covered. This research aims at providing an overview of the competitive environment while also researching the various business strategies implemented by the top players in the industry. Sales, revenue, and market shares are provided by the company data for each firm. The overall market competitive position in terms of the performance of key players has been discussed.

Market Dynamics

This study has covered the major factors impacting all companies that operate in this industry which, in effect, have a significant impact on the overall industry. The market for the products and services was analyzed to determine the main drivers of the demand. Also, the report covers the main industry-specific challenges and threats for defining the market's primary growth and high-risk segments. This study has covered the impact of fluctuations in supply and demand on the market, as well as overall prices. The infrastructural and technological developments which drive the demand in this industry are also studied.

Segmental Analysis

The segmentation of the Global Kidney Medicine Market into the relevant submarkets has been done to help research the structure of the market. The individual output of those submarkets has been analyzed to determine the key growth segments. On the Global Kidney Medicine Market, the main regions are listed as North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. The report provides a thorough analysis of all the Global Kidney Medicine Market's major components and provides a forecast for each market segment.

Report covers:

Comprehensive research methodology of Global Kidney Medicine Market.
This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Kidney Medicine Market.
Insights about market determinants which are stimulating the Global Kidney Medicine Market.
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

For any query @  https://www.wiseguyreports.com/enquiry/5123242-global-kidney-medicine-market-research-report-2020

Some points from table of content:

1 Kidney Medicine Market Overview
2 Global Kidney Medicine Market Competition by Manufacturers
3 Kidney Medicine Retrospective Market Scenario by Region
4 Global Kidney Medicine Historic Market Analysis by Type
5 Global Kidney Medicine Historic Market Analysis by Application
6 Company Profiles and Key Figures in Kidney Medicine Business
6.1 Pfizer
6.1.1 Corporation Information
6.1.2 Pfizer Description, Business Overview and Total Revenue
6.1.3 Pfizer Kidney Medicine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Pfizer Products Offered
6.1.5 Pfizer Recent Development
6.2 Roche
6.2.1 Roche Kidney Medicine Production Sites and Area Served
6.2.2 Roche Description, Business Overview and Total Revenue
6.2.3 Roche Kidney Medicine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Roche Products Offered
6.2.5 Roche Recent Development
6.3 Sanofi
6.3.1 Sanofi Kidney Medicine Production Sites and Area Served
6.3.2 Sanofi Description, Business Overview and Total Revenue
6.3.3 Sanofi Kidney Medicine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Sanofi Products Offered
6.3.5 Sanofi Recent Development
6.4 Novartis
6.4.1 Novartis Kidney Medicine Production Sites and Area Served
6.4.2 Novartis Description, Business Overview and Total Revenue
6.4.3 Novartis Kidney Medicine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novartis Products Offered
6.4.5 Novartis Recent Development
6.5 Amgen
6.5.1 Amgen Kidney Medicine Production Sites and Area Served
6.5.2 Amgen Description, Business Overview and Total Revenue
6.5.3 Amgen Kidney Medicine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Amgen Products Offered
6.5.5 Amgen Recent Development
6.6 Xiuzheng Pharmaceutical Group
6.6.1 Xiuzheng Pharmaceutical Group Kidney Medicine Production Sites and Area Served
6.6.2 Xiuzheng Pharmaceutical Group Description, Business Overview and Total Revenue
6.6.3 Xiuzheng Pharmaceutical Group Kidney Medicine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Xiuzheng Pharmaceutical Group Products Offered
6.6.5 Xiuzheng Pharmaceutical Group Recent Development
6.7 Xiaolin Zhiyao
6.6.1 Xiaolin Zhiyao Kidney Medicine Production Sites and Area Served
6.6.2 Xiaolin Zhiyao Description, Business Overview and Total Revenue
6.6.3 Xiaolin Zhiyao Kidney Medicine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Xiaolin Zhiyao Products Offered
6.7.5 Xiaolin Zhiyao Recent Development
6.8 Henan Lingrui Pharmaceutical
6.8.1 Henan Lingrui Pharmaceutical Kidney Medicine Production Sites and Area Served
6.8.2 Henan Lingrui Pharmaceutical Description, Business Overview and Total Revenue
6.8.3 Henan Lingrui Pharmaceutical Kidney Medicine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Henan Lingrui Pharmaceutical Products Offered
6.8.5 Henan Lingrui Pharmaceutical Recent Development
6.9 Kuihua yaoye
6.9.1 Kuihua yaoye Kidney Medicine Production Sites and Area Served
6.9.2 Kuihua yaoye Description, Business Overview and Total Revenue
6.9.3 Kuihua yaoye Kidney Medicine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Kuihua yaoye Products Offered
6.9.5 Kuihua yaoye Recent Development
6.10 Sanjiu Pharmaceutical
6.10.1 Sanjiu Pharmaceutical Kidney Medicine Production Sites and Area Served
6.10.2 Sanjiu Pharmaceutical Description, Business Overview and Total Revenue
6.10.3 Sanjiu Pharmaceutical Kidney Medicine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Sanjiu Pharmaceutical Products Offered
6.10.5 Sanjiu Pharmaceutical Recent Development
6.11 Harbin Pharmaceutical Group
6.11.1 Harbin Pharmaceutical Group Kidney Medicine Production Sites and Area Served
6.11.2 Harbin Pharmaceutical Group Kidney Medicine Description, Business Overview and Total Revenue

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
08411985042
email us here


Source: EIN Presswire